CVE-2026-48273: critical vulnerability in Adobe ColdFusion 2023
ColdFusion | Improper Neutralization of Directives in Dynamically Evaluated Code ('Eval Injection') (CWE-95)
Published · Updated
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
28Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 9.9epss 1.3%
ColdFusion is affected by an Improper Neutralization of Directives in Dynamically Evaluated Code ('Eval Injection') vulnerability that could result in arbitrary code execution in the context of the current user. A low-privileged attacker could exploit this vulnerability to execute arbitrary code. Exploitation of this issue does not require user interaction. Scope is changed.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Related CVEs — Adobe ColdFusion 2023
In the same product, most dangerous first.
CVE-2026-48282CRITICALColdFusion | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') (CWE-22)EPSS 42.4%KEVCVE-2026-27305HIGHColdFusion | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') (CWE-22)EPSS 26.3%CVE-2026-34619HIGHColdFusion | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') (CWE-22)EPSS 7.6%CVE-2026-27304CRITICALColdFusion | Improper Input Validation (CWE-20)EPSS 3.6%CVE-2026-48362CRITICALColdFusion | Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection') (CWE-78)EPSS 3.5%CVE-2026-48313CRITICALColdFusion | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') (CWE-22)EPSS 3.0%